TP53 and breast carcinoma: Molecular analysis, however, showed that increased intratumoural MVD, c-erbB-2 membrane overexpression, accumulation of mutant p53 protein and high proliferation index assessed with the MIB-1 MoAb defines subgroups of patients with increased risk of local relapse, in high-risk breast cancer patients.